About Corino Therapeutics
Corino Therapeutics is a Pharmaceuticals company, headquartered in New York, with 2 - 10 employees and annual revenue of $100k - $1M.
Transthyretin, orphan drug, pharmaceutical company, amyloidosis, TTR, polyneuropathy, cardiomyopathy, leptomeningeal, ATTR, Corino
Seamless Pro Tip
Use this information to figure out if this company is an ideal customer for you.
Corino Therapeutics Company Highlights
Phone Number
(704) 807-xxxx
Corporate Office Address
New York
Website
Corino Therapeutics Org
Corino Therapeutics has 1 VP employees.
Corino Therapeutics Decision Makers
- CEOMichael Roberts
Corino Therapeutics's Tech Stack
Frequently Asked Questions About
Corino Therapeutics
Log in or sign up to get full contact details and additional support.
Who is the CEO of Corino Therapeutics?
The CEO of Corino Therapeutics is Michael Roberts. See full contact details ›
How many senior employees does Corino Therapeutics have?
Corino Therapeutics has 1 senior employees that are typically used for decision making.
Who are the key decision makers at Corino Therapeutics?
Key decision makers at Corino Therapeutics include Michael Roberts (CEO). See full contact details ›
What technologies does Corino Therapeutics use?
Corino Therapeutics uses technologies including AngularJS, Lua, and OpenResty.
How do I contact Corino Therapeutics?
To contact Corino Therapeutics, visit corinorx.com.
Where is Corino Therapeutics headquartered?
Corino Therapeutics is headquartered in New York.
What is the main phone number for Corino Therapeutics?
The main phone number for Corino Therapeutics is (704) 807-xxxx.
What is the official website for Corino Therapeutics?
The official website for Corino Therapeutics is corinorx.com.
What is the annual revenue of Corino Therapeutics?
The annual revenue of Corino Therapeutics is $100k - $1M.
How many employees does Corino Therapeutics have?
Corino Therapeutics has 2 - 10 employees.
What industry is Corino Therapeutics in?
Corino Therapeutics is in the Pharmaceuticals industry.
Last updated: August 19, 2024